Table 5.
Regular Medications for Participants With Total Cardiovascular Disease in Urban and Rural Communities in Different Socioeconomic Regions of China
| Medications | High‐Income Regions | Middle‐Income Regions | Low‐Income Regions | |||
|---|---|---|---|---|---|---|
| Urban (n=1128) | Rural (n=722) | Urban (n=530) | Rural (n=225) | Urban (n=479) | Rural (n=465) | |
| Antiplatelet drugs | 205 (18.17) | 213 (29.50) | 136 (25.66) | 30 (13.33) | 38 (7.93) | 14 (3.01) |
| β‐Blockers | 83 (7.36) | 23 (3.19) | 58 (10.94) | 11 (4.89) | 32 (6.68) | 5 (1.08) |
| ACE inhibitors or ARBs | 114 (10.11) | 70 (9.70) | 44 (8.30) | 14 (6.22) | 30 (6.26) | 15 (3.23) |
| Diuretics | 182 (16.13) | 143 (19.81) | 71 (13.40) | 26 (11.56) | 40 (8.35) | 16 (3.44) |
| Calcium‐channel blockers | 178 (15.78) | 100 (13.85) | 157 (29.62) | 22 (9.78) | 45 (9.39) | 3 (0.65) |
| Blood‐pressure‐lowering drugsa | 436 (38.65) | 261 (36.15) | 252 (47.55) | 52 (23.11) | 117 (24.43) | 34 (7.31) |
| Statins | 25 (2.22) | 2 (0.28) | 20 (3.77) | 5 (2.22) | 4 (0.84) | 0 |
Data are presented as n (%). ACE indicates angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker.
a
Blood‐pressure‐lowering drugs include β‐blockers, ACE inhibitors, ARBs, diuretics, and calcium‐channel blockers.